Providing you with trustworthy and empathetic mental health information and advice to help you get the best every day.
Par Olive, the Australian ingestible wellness brand founded by Olivia Boyd-Smith, has unveiled a new supplement designed to target skin health from within. The company’s Advanced Skin Multivitamin, now available…
The global body-positivity movement that defined much of the 2010s is facing a profound test in the age of powerful new weight-loss drugs. A decade ago, plus-size model Tess Holliday…
Pfizer is positioning itself for what it believes could become a massive consumer-driven market for obesity medicines, comparable to the surge it experienced after launching Viagra more than two decades…
A Chinese pharmaceutical company, Huadong Medicine, has announced that its newly developed weight-loss drug for cats is undergoing the market approval process, sparking discussions among pet owners and netizens. According…
A recent 12-month study confirms that home-based, helmet-style low-level laser therapy (LLLT) is a safe and effective treatment for androgenetic alopecia, offering significant improvements in hair density and thickness. The…
Legacy Healthcare announced today that it will advance its topical botanical solution, Cinainu, into an international Phase 3 clinical trial (RAAINBOW-2) for patients with moderate to severe alopecia areata (AA)…
Sai De Silva has opened up about her cosmetic surgery history and her future on The Real Housewives of New York City during a candid “Ask Me a Question” session…
After a whirlwind week that took him from New York to Los Angeles and straight onto the Golden Globes red carpet, 24-year-old Heated Rivalry star Hudson Williams looked remarkably fresh…
The Better Business Bureau (BBB) has issued a nationwide consumer alert after uncovering a surge in scams involving deep-fake videos used to promote a weight-loss supplement called LipoMax, which is…
Novo Nordisk has officially launched an oral version of its blockbuster weight-loss drug Wegovy in the United States, marking a major milestone in the fast-growing obesity treatment market. The once-daily…
Alkem Laboratories has announced the launch of its Renocia Cyclical Therapy Kit, a scientifically designed weekly nutritional supplementation programme aimed at supporting hair growth, strengthening hair follicles and managing hair…
New York and Louisiana have become the first U.S. states to require private health insurers to cover scalp cooling, a medical technology proven to reduce or prevent hair loss in…
Eli Lilly (LLY.N) announced on Thursday that its late-stage clinical trial found the weight-loss drug Zepbound, when used alongside its psoriatic arthritis treatment Taltz, significantly improved arthritis symptoms while promoting…
The boss of Greggs has confirmed that the surge in popularity of appetite-suppressing drugs is driving customers to seek smaller, healthier portions, affecting the bakery chain’s profits. Roisin Currie, managing…
Jessa Duggar is celebrating a significant milestone in her postpartum journey. Five months after welcoming her sixth child, son Edward Owen, with husband Ben Seewald, the Counting On star revealed…
Cynthia Erivo, the powerhouse star of Broadway’s Wicked, is no stranger to reinvention. Once known for her long locks, Erivo made a conscious choice to change her hairstyle, sparking curiosity…
Consumers are being urged to avoid hair products containing the chemical glyoxylic acid following the hospitalization of a 17-year-old girl who developed severe kidney failure after a hair-straightening treatment at…
As the popularity of GLP-1 weight loss medications like Ozempic continues to rise, scammers are increasingly targeting consumers with fake offers, fraudulent websites, and misleading promotions. The Wisconsin Better Business…
A new real-world study shows that bariatric surgery dramatically outperforms popular weight loss medications, including GLP-1 receptor agonists like semaglutide and tirzepatide, in achieving significant, lasting weight reduction. The research,…
In early 2025, an estimated 4.9 million British adults—nearly one in ten—reported using or expressing interest in glucagon-like peptide-1 (GLP-1) or dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist medications to…
Healthfieldtips Your path to optimal health starts here! Discover curated insights into men’s fitness, women’s health, and mental health. So you can live a healthy and fulfilling life. Join us on your health journey!
【Contact us: [email protected]】
Copyright © 2026 — Healthfieldtips.com
